Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year
Tirzepatide is a once-weekly injectable medication approved for type 2 diabetes and chronic weight management, offering patients flexibility in administration timing
News provided by CVS Health Jun 22, 2026, 08:00 ET New $50 monthly copay for eligible Medicare patients, one-on-one pharmacist guidance, and over-the-counter products to help manage common side effects available to support patients MinuteClinic expands virtual care with new weight management offering and $49 visits WOONSOCKET, R.I., June 22, 2026 /PRNewswire/ -- As demand for GLP-1 medications continues to increase across the U.S., CVS Health (NYSE: CVS) today announced a comprehensive approach to GLP-1 support spanning its more than 9,000 CVS Pharmacy locations and MinuteClinic, available virtually in nearly all states
Statistical significance was assessed by two-way ANOVA followed by uncorrected Fishers Least Significant Difference (LSD) test in d - h